Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn


Blackmores hit by Aust vitamin sales slump

Simone Ziaziaris  |  29 Aug 2017Text size  Decrease  Increase  |  
Email to Friend

Page 1 of 1

SYDNEY - [AAP] Vitamin maker Blackmores' (ASX: BKL) full-year profit has tumbled 41 per cent to $59 million on the back of a slump in Australian sales due to a decline in Chinese consumers.

The company said potential regulatory changes in China had impacted the buying patterns of Chinese entrepreneurs and tourists who previously were purchasing Blackmores products through Australian stores.

It said the reduction was significant and came without warning, particularly in the first half of the year when Australian sales revenue suffered a 31 per cent fall to $158 million.

Full-year revenue from ordinary activities fell 3 per cent to $692.8 million with the bulk of sales coming from the Australian and New Zealand arm despite a 23 per cent drop compared to a year ago.

But Asia direct sales were up 36 per cent to $216 million, while its BioCeuticals Group, which includes the BioCeuticals and the Global Therapeutics brands also grew with sales of $102 million.

"The demand for Blackmores' products in China remained strong throughout the year although the route to serve it has changed significantly," the company said on Tuesday.

Blackmores said it responded quickly to the changes and was able to close the year with direct sales in China up 71 per cent to $132 million.

Email to Friend
Market News and Views Sign up today and receive our free Morning Note e-newsletter, daily in your inbox.

The vitamin maker said it had increased its inventory provisions from $2 million to $14 million to protect against possible future uncertainty, which had impacted earnings by around $10 million for the full year.

It said it expects regulation, pricing, and evolving market conditions to continue to provide challenges in the year ahead but, notwithstanding these challenges, believes its Asia division, particularly China, will strengthen.


* Net profit down 41pct to $59m

* Revenue down 3pt to $692.8m

* Final dividend of $1.40, fully franked, vs $2.10


AAP logo image

© [2017] Australian Associated Press Pty Limited (AAP) or its Licensors. This is the Morningstar service with content provided by AAP where indicated. AAP reserves all rights, including copyright, in services provided by it. The information in the service is for personal use only, does not constitute financial product advice (whether general or personal) and may not be re-written, copied, re-sold or re-distributed, framed, linked or otherwise used whether for compensation of any kind or not, without the prior written permission of AAP. You should seek advice from a professional financial adviser before making decision to acquire or dispose of a financial product.

This service is published for general information purposes only without assuming a duty of care. AAP is not in the business of providing financial product advice (whether personal or general advice), and gives no warranty, guarantee or other representation about the accuracy of the information or images contained in this service. AAP is not liable for errors, omissions in, delays or interruptions to or cessation of the services through negligence or otherwise. The globe symbol and "AAP" are registered trademarks.

Email To Friend